Results 101 to 110 of about 27,314 (241)

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma

Hepatology Research, EarlyView.
In this study, we assessed patients with cancer of the liver bile ducts (intrahepatic cholangiocarcinoma) or cancer in bile ducts just outside the liver (perihilar cholangiocarcinoma) to see what factors were most commonly found in patients with fusions (and/or rearrangements) of the FGFR2 gene, a prominent target in bile duct cancer. Overall, we found
Tomoyuki Satake, Chigusa Morizane, Hiroyuki Isayama, Akio Katanuma, Masato Endo, Noritoshi Kobayashi, Yasushi Kojima, Shoji Kubo, Saburo Matsubara, Takeshi Shiraishi, Takashi Ohta, Tadashi Uwagawa, Shingo Kobayashi, Takatoshi Sahara, Setsuo Funasaka, Hiroki Ikezawa, Takuji Okusaka   +16 more
wiley   +1 more source

The Landscape of SPP1+ Macrophages Across Tissues and Diseases: A Comprehensive Review

Immunology, EarlyView.
SPP1+ macrophages represent a conserved, disease‐associated population present across cancerous and non‐cancerous conditions, involved in immunosuppression, fibrosis, lipid metabolism, phagocytosis, and other cellular processes. This review highlights their shared molecular programmes across tissues, their interactions with stromal and immune cells ...
Alessandro Palma
wiley   +1 more source

Congenital Dilatation of Intrahepatic Biliary Ducts with Cholangiocarcinoma [PDF]

, 1970
A. W. Jones, D R Shreeve
openalex   +1 more source

Two Varieties of Intrahepatic Cholangiocarcinoma [PDF]

HPB Surgery, 1994
Background. To find the rational surgical strategy for the treatment of intrahepatic cholangiocarcinoma (ICC), clinical features of ICC were studied in 20 patients who underwent hepatic resection in the National Cancer Center Hospital from 1980 to 1990. Methods.
openaire   +3 more sources

PRRT plus holmium‐166‐SIRT (HEPAR PLuS) versus PRRT‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis

Journal of Neuroendocrinology, EarlyView.
Abstract Patients with bulky neuroendocrine liver metastases (NELM) undergoing PRRT with [177Lu]Lu‐DOTATATE have a worse survival than patients with limited liver metastases. Previously, the safety and efficacy of additional selective internal radiotherapy (SIRT), using holmium‐166 (166Ho)‐microspheres, directly following PRRT in patients with NELM ...
W. B. Veldhuis, T. Walter, D. M. V. de Vries‐Huizing, J. Theysohn, S. Barton, E. D. Ekkelenkamp, B. Lachachi, R. J. G. de Jong, L. W. van Golen, H. Lanzafame, L. Milot, H. Lahner, M. E. G. H. Lam, M. E. T. Tesselaar, A. J. A. T. Braat   +14 more
wiley   +1 more source

Recent Updates in the Imaging Diagnosis of Cholangiocarcinoma

대한영상의학회지, 2019
Cholangiocarcinoma is a disease entity with a wide spectrum of imaging, histological, and clinical features as well as treatment options. At present, imaging studies are essential for the detection, characterization, staging, and resectability assessment
Ijin Joo
doaj   +1 more source

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature

Surgical Case Reports, 2018
Background Hepatic carcinosarcomas, which include both carcinomatous and sarcomatous elements, are uncommon in adults. Although carcinosarcoma in hepatocellular carcinoma is occasionally reported, carcinosarcoma in intrahepatic cholangiocarcinoma (ICC ...
Kyohei Yugawa, Tomoharu Yoshizumi, Yohei Mano, Noboru Harada, Shinji Itoh, Toru Ikegami, Yuji Soejima, Nobuhiro Fujita, Kenichi Kohashi, Shinichi Aishima, Yoshinao Oda, Masaki Mori   +11 more
doaj   +1 more source

Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases [PDF]

, 1993
Tohru Nakajima, Yasuo Tajima, Isamu Sugano, Kōichi Nagao, Yōichirō Kondō, Katsunori Wada   +5 more
openalex   +1 more source

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J. Allen, Andrew Barbas, Debra Sudan, Lindsay King, Carl Berg, Charles Kim, Mustafa Bashir, Manisha Palta, Michael A. Morse, Michael E. Lidsky   +12 more
wiley   +1 more source

Lipid Metabolism and Immune Function: Chemical Tools for Insights into T‐Cell Biology

ChemBioChem, Volume 26, Issue 11, June 3, 2025.
This review explores how lipids regulate immune responses, particularly in T‐cell function. Advances in metabolomics and proteomics provide insights into lipid‐mediated immunity. Fluorescent lipids enable single‐cell analysis of lipid uptake and metabolism.
Luuk Reinalda, Mario van der Stelt, Sander Izaak van Kasteren   +2 more
wiley   +1 more source